Attempting to lose weight beyond a healthy range can lead to nutrient deficiencies, muscle loss, bone density issues, and other adverse health outcomes, as well as potentially fostering unhealthy relationships with food and body image
This dual benefit is part of the rationale for filing CagriSema in both obesity and T2D contexts
Selective novel inverse agonists for human GPR43 augment GLP-1 secretion
year-long RCT dataset in type 1 & type 2 diabetes, but research-vial use is off-label / research-only
Answer: Treatment options include nonsurgical treatments like injections, oral medicines, and medical therapies, as well as surgical options such as grafting, plication, and device implantation